Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to
highly challenging (eg, fear, grief, and paranoia). These challenging experiences contribute …

Background and aims Scientific interest in the therapeutic potential of psychedelics has
been experiencing significant growth. Understanding the perceptions of psychedelic …

Although there is research interest to assess attitudes on psychedelics, no validated
instrument exists for this purpose. We aimed to develop and examine the psychometric …

Background An advanced cancer diagnosis can be associated with a significant profile of
distress. Psychedelic compounds have shown clinically significant effects in the treatment of …

Introduction This study evaluates the impact of a two-hour team-based learning (TBL)
curriculum on medical students' knowledge, comprehension, ethical understanding, and …

Objectives A resurgence of research investigating the administration of psychedelic
compounds alongside psychotherapy suggests that this treatment is a promising …

Introduction Although certain psychedelic agents may soon gain federal approval for use in
treating specific psychiatric conditions, the utilization of such therapies in clinical practice will …

Background Psilocybin has been studied for its potential therapeutic benefits, particularly for
the treatment of psychiatric disorders such as anxiety, depression, and obsessive …

People with cancer experience higher rates of psychological dysfunction than the general
population, with extreme inequity among indigenous people. Psychedelic-assisted therapy …

Introduction and aim It is important to understand how mental health practitioners view
recent findings on psychedelic-assisted psychotherapy (PAP) as there is potential this …